Denmark· DK-28107076023

KAYFANDA

A odevixibat product containing odevixibatsesquihydrat, registered in Denmark by Ipsen Pharma. The same ATC class is registered in 15 of our 19 countries.

ATC A05AX05

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedKAYFANDAATCA05AX05REGISTER NO.DK-28107076023PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Odevixibat is registered in 15 of 19 countries.

Countries holding a registration under ATC A05AX05 (odevixibat), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 9 of them publish a price we can compare per daily dose

Odevixibat · ATC A05AX05

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Odevixibatsesquihydrat
Manufacturer
Ipsen Pharma
Country
Denmark (DK)
ATC code
A05AX05
ATC class
Odevixibat
Defined daily dose
2.4 mg, O
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28107076023

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f624c0c3-c5d5-4aae-ac21-8240df8f7a4a
GET /v1/drugs/f624c0c3-c5d5-4aae-ac21-8240df8f7a4a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "kapsler, hårde",
  "source": "dkma",
  "strength": "600 mikg",
  "auth_role": "MOD",
  "dk_drugid": "28107076023",
  "substance": "Odevixibatsesquihydrat",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "45554"
}

See everything about odevixibat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.